Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model

Proinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells. However, the role of IL-33-ST2L and the IL-33 decoy receptor sST2 in the tumor microenvironment of pancreatic cancer is unclear. Because we previously reporte...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 15; no. 4; p. e0232230
Main Authors Takenaga, Keizo, Akimoto, Miho, Koshikawa, Nobuko, Nagase, Hiroki
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 27.04.2020
Public Library of Science (PLoS)
Subjects
Biology and Life Sciences
Cancer cells
CD20 antigen
Chemokines
Colon
Colon cancer
Colorectal cancer
CXCR2 protein
Cytokines
Enzyme-linked immunosorbent assay
Fibroblasts
Gene expression
Growth
House mouse
Immunohistochemistry
Inflammation
Interleukins
Laboratory animals
Leukocytes (neutrophilic)
Macrophages
Medicine and Health Sciences
Messenger RNA
Pancreas
Pancreatic cancer
Pharmaceutical industry
R&D
Receptors
Research & development
Research and Analysis Methods
RNA
Signaling
Therapeutic applications
Time
Tissues
Tumor cell lines
Tumors
United States
Japan
United States > US
Online AccessGet full text

Cover

Abstract Proinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells. However, the role of IL-33-ST2L and the IL-33 decoy receptor sST2 in the tumor microenvironment of pancreatic cancer is unclear. Because we previously reported that sST2 derived from colon cancer cells profoundly influences malignant tumor growth, we hypothesized that sST2 released from pancreatic cancer cells also modulates IL-33-ST2L signaling in the tumor microenvironment, thereby influencing tumor growth. ST2 (ST2L and sST2) expression in mouse pancreatic cancer Panc02 cells was downregulated by shRNAs. mRNA expression levels of IL-33, ST2, cytokines and chemokines in the cells and tumor tissues were examined using real-time PCR. sST2 secretion and the amount of CXCL3 in tumor tissues were measured using ELISA. Tumor growth was investigated after injection of the cells into the pancreas of C57BL/6 mice. MPO+, F4/80+ and CD20+ cells in tumor tissues were detected using immunohistochemistry. Some but not all human and mouse pancreatic cancer cell lines preferentially expressed sST2. Then, we investigated the role of sST2 in orthotopic tumor growth of sST2-expressing mouse pancreatic cancer Panc02 cells in immunocompetent mice. shRNA-mediated knockdown of sST2 expression in the cells suppressed orthotopic tumor growth, which was partially recovered by overexpression of shRNA-resistant sST2 mRNA but was not evident in IL-33 knockout mice. This was associated with decreases in Cxcl3 expression, vessel density and accumulation of cancer-associated neutrophils but not cancer-associated macrophages. Administration of SB225002, an inhibitor of the CXCL3 receptor CXCR2, induced similar effects. Cancer cell-derived sST2 enhances tumor growth through upregulation of CXCL3 via inhibition of IL-33-ST2L signaling in the tumor microenvironment of pancreatic cancer. These results suggest that the sST2 and the CXCL3-CXCR2 axis could be therapeutic targets.
AbstractList Proinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells. However, the role of IL-33-ST2L and the IL-33 decoy receptor sST2 in the tumor microenvironment of pancreatic cancer is unclear. Because we previously reported that sST2 derived from colon cancer cells profoundly influences malignant tumor growth, we hypothesized that sST2 released from pancreatic cancer cells also modulates IL-33-ST2L signaling in the tumor microenvironment, thereby influencing tumor growth. ST2 (ST2L and sST2) expression in mouse pancreatic cancer Panc02 cells was downregulated by shRNAs. mRNA expression levels of IL-33, ST2, cytokines and chemokines in the cells and tumor tissues were examined using real-time PCR. sST2 secretion and the amount of CXCL3 in tumor tissues were measured using ELISA. Tumor growth was investigated after injection of the cells into the pancreas of C57BL/6 mice. MPO+, F4/80+ and CD20+ cells in tumor tissues were detected using immunohistochemistry. Some but not all human and mouse pancreatic cancer cell lines preferentially expressed sST2. Then, we investigated the role of sST2 in orthotopic tumor growth of sST2-expressing mouse pancreatic cancer Panc02 cells in immunocompetent mice. shRNA-mediated knockdown of sST2 expression in the cells suppressed orthotopic tumor growth, which was partially recovered by overexpression of shRNA-resistant sST2 mRNA but was not evident in IL-33 knockout mice. This was associated with decreases in Cxcl3 expression, vessel density and accumulation of cancer-associated neutrophils but not cancer-associated macrophages. Administration of SB225002, an inhibitor of the CXCL3 receptor CXCR2, induced similar effects. Cancer cell-derived sST2 enhances tumor growth through upregulation of CXCL3 via inhibition of IL-33-ST2L signaling in the tumor microenvironment of pancreatic cancer. These results suggest that the sST2 and the CXCL3-CXCR2 axis could be therapeutic targets.
Proinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells. However, the role of IL-33-ST2L and the IL-33 decoy receptor sST2 in the tumor microenvironment of pancreatic cancer is unclear. Because we previously reported that sST2 derived from colon cancer cells profoundly influences malignant tumor growth, we hypothesized that sST2 released from pancreatic cancer cells also modulates IL-33-ST2L signaling in the tumor microenvironment, thereby influencing tumor growth. ST2 (ST2L and sST2) expression in mouse pancreatic cancer Panc02 cells was downregulated by shRNAs. mRNA expression levels of IL-33, ST2, cytokines and chemokines in the cells and tumor tissues were examined using real-time PCR. sST2 secretion and the amount of CXCL3 in tumor tissues were measured using ELISA. Tumor growth was investigated after injection of the cells into the pancreas of C57BL/6 mice. MPO.sup.+, F4/80.sup.+ and CD20.sup.+ cells in tumor tissues were detected using immunohistochemistry. Some but not all human and mouse pancreatic cancer cell lines preferentially expressed sST2. Then, we investigated the role of sST2 in orthotopic tumor growth of sST2-expressing mouse pancreatic cancer Panc02 cells in immunocompetent mice. shRNA-mediated knockdown of sST2 expression in the cells suppressed orthotopic tumor growth, which was partially recovered by overexpression of shRNA-resistant sST2 mRNA but was not evident in IL-33 knockout mice. This was associated with decreases in Cxcl3 expression, vessel density and accumulation of cancer-associated neutrophils but not cancer-associated macrophages. Administration of SB225002, an inhibitor of the CXCL3 receptor CXCR2, induced similar effects. Cancer cell-derived sST2 enhances tumor growth through upregulation of CXCL3 via inhibition of IL-33-ST2L signaling in the tumor microenvironment of pancreatic cancer. These results suggest that the sST2 and the CXCL3-CXCR2 axis could be therapeutic targets.
Background Proinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells. However, the role of IL-33-ST2L and the IL-33 decoy receptor sST2 in the tumor microenvironment of pancreatic cancer is unclear. Because we previously reported that sST2 derived from colon cancer cells profoundly influences malignant tumor growth, we hypothesized that sST2 released from pancreatic cancer cells also modulates IL-33-ST2L signaling in the tumor microenvironment, thereby influencing tumor growth. Methods ST2 (ST2L and sST2) expression in mouse pancreatic cancer Panc02 cells was downregulated by shRNAs. mRNA expression levels of IL-33, ST2, cytokines and chemokines in the cells and tumor tissues were examined using real-time PCR. sST2 secretion and the amount of CXCL3 in tumor tissues were measured using ELISA. Tumor growth was investigated after injection of the cells into the pancreas of C57BL/6 mice. MPO.sup.+, F4/80.sup.+ and CD20.sup.+ cells in tumor tissues were detected using immunohistochemistry. Results Some but not all human and mouse pancreatic cancer cell lines preferentially expressed sST2. Then, we investigated the role of sST2 in orthotopic tumor growth of sST2-expressing mouse pancreatic cancer Panc02 cells in immunocompetent mice. shRNA-mediated knockdown of sST2 expression in the cells suppressed orthotopic tumor growth, which was partially recovered by overexpression of shRNA-resistant sST2 mRNA but was not evident in IL-33 knockout mice. This was associated with decreases in Cxcl3 expression, vessel density and accumulation of cancer-associated neutrophils but not cancer-associated macrophages. Administration of SB225002, an inhibitor of the CXCL3 receptor CXCR2, induced similar effects. Conclusions Cancer cell-derived sST2 enhances tumor growth through upregulation of CXCL3 via inhibition of IL-33-ST2L signaling in the tumor microenvironment of pancreatic cancer. These results suggest that the sST2 and the CXCL3-CXCR2 axis could be therapeutic targets.
Background Proinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells. However, the role of IL-33-ST2L and the IL-33 decoy receptor sST2 in the tumor microenvironment of pancreatic cancer is unclear. Because we previously reported that sST2 derived from colon cancer cells profoundly influences malignant tumor growth, we hypothesized that sST2 released from pancreatic cancer cells also modulates IL-33-ST2L signaling in the tumor microenvironment, thereby influencing tumor growth. Methods ST2 (ST2L and sST2) expression in mouse pancreatic cancer Panc02 cells was downregulated by shRNAs. mRNA expression levels of IL-33, ST2, cytokines and chemokines in the cells and tumor tissues were examined using real-time PCR. sST2 secretion and the amount of CXCL3 in tumor tissues were measured using ELISA. Tumor growth was investigated after injection of the cells into the pancreas of C57BL/6 mice. MPO+, F4/80+ and CD20+ cells in tumor tissues were detected using immunohistochemistry. Results Some but not all human and mouse pancreatic cancer cell lines preferentially expressed sST2. Then, we investigated the role of sST2 in orthotopic tumor growth of sST2-expressing mouse pancreatic cancer Panc02 cells in immunocompetent mice. shRNA-mediated knockdown of sST2 expression in the cells suppressed orthotopic tumor growth, which was partially recovered by overexpression of shRNA-resistant sST2 mRNA but was not evident in IL-33 knockout mice. This was associated with decreases in Cxcl3 expression, vessel density and accumulation of cancer-associated neutrophils but not cancer-associated macrophages. Administration of SB225002, an inhibitor of the CXCL3 receptor CXCR2, induced similar effects. Conclusions Cancer cell-derived sST2 enhances tumor growth through upregulation of CXCL3 via inhibition of IL-33-ST2L signaling in the tumor microenvironment of pancreatic cancer. These results suggest that the sST2 and the CXCL3-CXCR2 axis could be therapeutic targets.
BackgroundProinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells. However, the role of IL-33-ST2L and the IL-33 decoy receptor sST2 in the tumor microenvironment of pancreatic cancer is unclear. Because we previously reported that sST2 derived from colon cancer cells profoundly influences malignant tumor growth, we hypothesized that sST2 released from pancreatic cancer cells also modulates IL-33-ST2L signaling in the tumor microenvironment, thereby influencing tumor growth.MethodsST2 (ST2L and sST2) expression in mouse pancreatic cancer Panc02 cells was downregulated by shRNAs. mRNA expression levels of IL-33, ST2, cytokines and chemokines in the cells and tumor tissues were examined using real-time PCR. sST2 secretion and the amount of CXCL3 in tumor tissues were measured using ELISA. Tumor growth was investigated after injection of the cells into the pancreas of C57BL/6 mice. MPO+, F4/80+ and CD20+ cells in tumor tissues were detected using immunohistochemistry.ResultsSome but not all human and mouse pancreatic cancer cell lines preferentially expressed sST2. Then, we investigated the role of sST2 in orthotopic tumor growth of sST2-expressing mouse pancreatic cancer Panc02 cells in immunocompetent mice. shRNA-mediated knockdown of sST2 expression in the cells suppressed orthotopic tumor growth, which was partially recovered by overexpression of shRNA-resistant sST2 mRNA but was not evident in IL-33 knockout mice. This was associated with decreases in Cxcl3 expression, vessel density and accumulation of cancer-associated neutrophils but not cancer-associated macrophages. Administration of SB225002, an inhibitor of the CXCL3 receptor CXCR2, induced similar effects.ConclusionsCancer cell-derived sST2 enhances tumor growth through upregulation of CXCL3 via inhibition of IL-33-ST2L signaling in the tumor microenvironment of pancreatic cancer. These results suggest that the sST2 and the CXCL3-CXCR2 axis could be therapeutic targets.
Background Proinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells. However, the role of IL-33-ST2L and the IL-33 decoy receptor sST2 in the tumor microenvironment of pancreatic cancer is unclear. Because we previously reported that sST2 derived from colon cancer cells profoundly influences malignant tumor growth, we hypothesized that sST2 released from pancreatic cancer cells also modulates IL-33-ST2L signaling in the tumor microenvironment, thereby influencing tumor growth. Methods ST2 (ST2L and sST2) expression in mouse pancreatic cancer Panc02 cells was downregulated by shRNAs. mRNA expression levels of IL-33, ST2, cytokines and chemokines in the cells and tumor tissues were examined using real-time PCR. sST2 secretion and the amount of CXCL3 in tumor tissues were measured using ELISA. Tumor growth was investigated after injection of the cells into the pancreas of C57BL/6 mice. MPO+, F4/80+ and CD20+ cells in tumor tissues were detected using immunohistochemistry. Results Some but not all human and mouse pancreatic cancer cell lines preferentially expressed sST2. Then, we investigated the role of sST2 in orthotopic tumor growth of sST2-expressing mouse pancreatic cancer Panc02 cells in immunocompetent mice. shRNA-mediated knockdown of sST2 expression in the cells suppressed orthotopic tumor growth, which was partially recovered by overexpression of shRNA-resistant sST2 mRNA but was not evident in IL-33 knockout mice. This was associated with decreases in Cxcl3 expression, vessel density and accumulation of cancer-associated neutrophils but not cancer-associated macrophages. Administration of SB225002, an inhibitor of the CXCL3 receptor CXCR2, induced similar effects. Conclusions Cancer cell-derived sST2 enhances tumor growth through upregulation of CXCL3 via inhibition of IL-33-ST2L signaling in the tumor microenvironment of pancreatic cancer. These results suggest that the sST2 and the CXCL3-CXCR2 axis could be therapeutic targets.
Audience Academic
Author Koshikawa, Nobuko
Nagase, Hiroki
Takenaga, Keizo
Akimoto, Miho
AuthorAffiliation University of Miami, UNITED STATES
1 Laboratory of Cancer Genetics, Chiba Cancer Center Research Institute, Nitona, Chuoh-ku, Chiba, Japan
2 Department of Biochemistry, Teikyo University School of Medicine, Kaga, Itabashi-ku, Tokyo, Japan
AuthorAffiliation_xml – name: University of Miami, UNITED STATES
– name: 2 Department of Biochemistry, Teikyo University School of Medicine, Kaga, Itabashi-ku, Tokyo, Japan
– name: 1 Laboratory of Cancer Genetics, Chiba Cancer Center Research Institute, Nitona, Chuoh-ku, Chiba, Japan
Author_xml – sequence: 1
  givenname: Keizo
  orcidid: 0000-0001-9127-2965
  surname: Takenaga
  fullname: Takenaga, Keizo
  organization: Laboratory of Cancer Genetics, Chiba Cancer Center Research Institute, Nitona, Chuoh-ku, Chiba, Japan
– sequence: 2
  givenname: Miho
  surname: Akimoto
  fullname: Akimoto, Miho
  organization: Department of Biochemistry, Teikyo University School of Medicine, Kaga, Itabashi-ku, Tokyo, Japan
– sequence: 3
  givenname: Nobuko
  surname: Koshikawa
  fullname: Koshikawa, Nobuko
  organization: Laboratory of Cancer Genetics, Chiba Cancer Center Research Institute, Nitona, Chuoh-ku, Chiba, Japan
– sequence: 4
  givenname: Hiroki
  surname: Nagase
  fullname: Nagase, Hiroki
  organization: Laboratory of Cancer Genetics, Chiba Cancer Center Research Institute, Nitona, Chuoh-ku, Chiba, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32340025$$D View this record in MEDLINE/PubMed
BookMark eNqNk9tu1DAQhiNURNuFN0AQCQnBRRYfcrxBqlYcVqpUiRZuLceZbLw4dmo7hYqXx9tNqw3qBfJFrPH3_-MZZ06jI200RNFLjJaYFvjD1oxWc7UcQniJCCWEoifRCa4oSXKC6NHB_jg6dW6LUEbLPH8WHVNCU4RIdhL9WXEtwMYClEoasPIGmlhqD1bB-FPqhNK4AWFuYwsCBm9s7C6vSAy62wldbKzvjDeDFLEf-3C8seaX74JHzON-tFJDPATUAveBEft0vWlAPY-etlw5eDF9F9H3z5-uVl-T84sv69XZeSKKrPRJQbKqojnBBRCMyoo2BcZlWqESt0IQnJekQghEg1JK6hynNS5InYZ-AK8BarqIXu99B2Ucm_rmGKFVRtKKkCIQ6z3RGL5lg5U9t7fMcMnuAsZuGLfh-gqYSEVDS4xxLrK0rNMyQwI3XAjIakyqNnh9nLKNdQ-NAO0tVzPT-YmWHduYG1bgMitCDYvo3WRgzfUIzrNeut37cA1m3N87p6hIq4C--Qd9vLqJ2vBQgNStCXnFzpSd5YRgXOA7r-UjVFgN9FKEn6yVIT4TvJ8JAuPht9_w0Tm2vvz2_-zFjzn79oDtgCvfOaNGL412czDdg8Ia5yy0D03GiO1m5L4bbDcjbJqRIHt1-EAPovuhoH8B95MNAQ
CitedBy_id crossref_primary_10_1371_journal_pone_0270677
crossref_primary_10_1073_pnas_2218033120
crossref_primary_10_1007_s12032_021_01590_y
crossref_primary_10_1016_j_cyto_2022_155961
crossref_primary_10_3390_cancers12123787
crossref_primary_10_1016_j_lfs_2024_122691
crossref_primary_10_1177_15353702221102094
crossref_primary_10_3390_cells10061385
crossref_primary_10_17352_oja_000015
Cites_doi 10.1093/jnci/dju124
10.1007/s10620-011-1760-5
10.1016/j.eururo.2016.02.033
10.4049/jimmunol.165.9.5269
10.1186/s12943-017-0707-7
10.4049/jimmunol.1401344
10.1002/j.1460-2075.1994.tb06367.x
10.1046/j.1365-2745.2002.01494.x
10.1038/nrclinonc.2011.182
10.1038/nrclinonc.2013.66
10.1093/rb/rbw041
10.1002/ijc.28481
10.1097/MPA.0b013e318288107a
10.1371/journal.pone.0126605
10.1016/0014-5793(89)81679-5
10.1177/030006051204000504
10.3748/wjg.v20.i40.14717
10.7314/APJCP.2013.14.4.2563
10.1200/JCO.2008.18.9498
10.1006/bbrc.2001.5306
10.1016/j.canlet.2013.03.002
10.18632/oncotarget.11809
10.1007/s12032-016-0880-3
10.1172/jci.insight.122375
10.1016/j.immuni.2010.07.012
10.1152/ajpheart.00153.2005
10.1016/j.immuni.2005.09.015
10.1371/journal.pone.0003331
10.1016/j.bbrc.2009.04.081
10.1038/ncomms13589
10.1038/s41388-018-0144-0
10.1586/17474124.2016.1117386
10.4049/jimmunol.175.8.5351
10.2741/s2
10.1074/jbc.271.34.20545
10.1136/annrheumdis-2011-200589
10.1016/j.cyto.2012.06.286
10.1016/j.cytogfr.2004.02.004
10.1007/978-3-0348-0837-8_2
10.14712/fb2014060040180
10.1038/nri2692
10.1111/j.1582-4934.2010.01051.x
10.1074/jbc.270.45.27348
10.2332/allergolint.10-RAI-0186
10.1073/pnas.1003059107
10.1016/j.canlet.2008.04.050
ContentType Journal Article
Copyright COPYRIGHT 2020 Public Library of Science
2020 Takenaga et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2020 Takenaga et al 2020 Takenaga et al
Copyright_xml – notice: COPYRIGHT 2020 Public Library of Science
– notice: 2020 Takenaga et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2020 Takenaga et al 2020 Takenaga et al
DBID NPM
AAYXX
CITATION
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0232230
DatabaseName PubMed
CrossRef
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest Central
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agriculture Science Database
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Biological Science Collection
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
Technology Collection
Technology Research Database
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed





Agricultural Science Database


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Role of sST2 in pancreatic cancer growth
EISSN 1932-6203
Editor Banerjee, Sulagna
Editor_xml – sequence: 1
  givenname: Sulagna
  surname: Banerjee
  fullname: Banerjee, Sulagna
EndPage e0232230
ExternalDocumentID 2395249227
oai_doaj_org_article_c4cd381116c548b4850c1dacce5b129f
A622117149
10_1371_journal_pone_0232230
32340025
Genre Journal Article
GeographicLocations United States
Japan
United States--US
GeographicLocations_xml – name: Japan
– name: United States
– name: United States--US
GrantInformation_xml – fundername: ;
  grantid: 24791422
– fundername: ;
  grantid: 25430110
GroupedDBID ---
123
29O
2WC
3V.
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BBORY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESTFP
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
IOV
IPNFZ
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
NPM
O5R
O5S
OK1
P2P
P62
PATMY
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RIG
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
AAYXX
ALIPV
CITATION
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PQEST
PQUKI
PRINS
RC3
7X8
5PM
AAPBV
ABPTK
ID FETCH-LOGICAL-c758t-7259936217e210893d711849081fcc21682900ecd0432b614b172b4223eabeeb3
IEDL.DBID RPM
ISSN 1932-6203
IngestDate Sun Sep 03 00:14:22 EDT 2023
Fri Jul 05 11:51:13 EDT 2024
Tue Sep 17 21:17:10 EDT 2024
Wed Jul 24 17:00:58 EDT 2024
Fri Sep 13 02:32:13 EDT 2024
Thu Feb 22 23:34:27 EST 2024
Fri Feb 02 04:28:44 EST 2024
Thu Aug 01 20:34:10 EDT 2024
Thu Aug 01 19:45:24 EDT 2024
Tue Aug 20 22:13:31 EDT 2024
Wed Aug 07 14:02:15 EDT 2024
Thu May 23 23:43:54 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c758t-7259936217e210893d711849081fcc21682900ecd0432b614b172b4223eabeeb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: The authors declare that they have no competing interests.
ORCID 0000-0001-9127-2965
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185704/
PMID 32340025
PQID 2395249227
PQPubID 1436336
PageCount e0232230
ParticipantIDs plos_journals_2395249227
doaj_primary_oai_doaj_org_article_c4cd381116c548b4850c1dacce5b129f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7185704
proquest_miscellaneous_2395630749
proquest_journals_2395249227
gale_infotracmisc_A622117149
gale_infotracacademiconefile_A622117149
gale_incontextgauss_ISR_A622117149
gale_incontextgauss_IOV_A622117149
gale_healthsolutions_A622117149
crossref_primary_10_1371_journal_pone_0232230
pubmed_primary_32340025
PublicationCentury 2000
PublicationDate 2020-04-27
PublicationDateYYYYMMDD 2020-04-27
PublicationDate_xml – month: 04
  year: 2020
  text: 2020-04-27
  day: 27
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2020
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References M Akimoto (pone.0232230.ref027) 2015; 10
K Oboki (pone.0232230.ref029) 2010; 107
GS Selders (pone.0232230.ref040) 2017; 4
TH Corbett (pone.0232230.ref028) 1984; 44
HK Jensen (pone.0232230.ref042) 2009; 27
M Hoover (pone.0232230.ref049) 2017; 8
A Ocana (pone.0232230.ref038) 2017; 16
IS Wood (pone.0232230.ref013) 2009; 384
S. Tominaga (pone.0232230.ref006) 1989; 258
P Zhang (pone.0232230.ref019) 2012; 40
C Moussion (pone.0232230.ref012) 2008; 3
L-A Hu (pone.0232230.ref018) 2013; 14
V Trajkovic (pone.0232230.ref009) 2004; 15
RM Strieter (pone.0232230.ref035) 1995; 270
M Erkan (pone.0232230.ref003) 2016; 10
J Mestas (pone.0232230.ref037) 2005; 175
P Andersson (pone.0232230.ref044) 2018; 3
M Akimoto (pone.0232230.ref022) 2016; 7
E Ben-Josef (pone.0232230.ref005) 2012; 9
OM Steinmetz (pone.0232230.ref030) 2009; 1
J Schmitz (pone.0232230.ref016) 2005; 23
DF Smith (pone.0232230.ref031) 2005; 289
AJ Templeton (pone.0232230.ref041) 2016; 70
J Werner (pone.0232230.ref004) 2013; 10
AJ Templeton (pone.0232230.ref039) 2014; 106
N Reich (pone.0232230.ref033) 2011; 15
CL Addison (pone.0232230.ref036) 2000; 165
FY Liew (pone.0232230.ref008) 2012; 71
SK Ahuja (pone.0232230.ref032) 1996; 271
K Oshikawa (pone.0232230.ref011) 2002; 32
K Takahashi (pone.0232230.ref048) 2018; 37
WS Loc (pone.0232230.ref001) 2014; 20
C. Partensky (pone.0232230.ref002) 2013; 42
J Vandercappellen (pone.0232230.ref034) 2008; 267
NB Janakira (pone.0232230.ref021) 2014; 816
Y Fang (pone.0232230.ref026) 2017; 34
M Akimoto (pone.0232230.ref047) 2018
K Tago (pone.0232230.ref007) 2001; 285
R Bonecchi (pone.0232230.ref045) 2010; 341
A Schmieder (pone.0232230.ref025) 2012; 60
EK Koltsova (pone.0232230.ref046) 2010; 33
IP Jovanovic (pone.0232230.ref020) 2014; 134
E Brabcová (pone.0232230.ref043) 2014; 60
G Bergers (pone.0232230.ref010) 1994; 13
K Oboki (pone.0232230.ref014) 2010; 59
FY Liew (pone.0232230.ref015) 2010; 10
K Gao (pone.0232230.ref023) 2013; 335
P Sun (pone.0232230.ref017) 2011; 56
X Gao (pone.0232230.ref024) 2015; 194
References_xml – volume: 106
  start-page: dju124
  year: 2014
  ident: pone.0232230.ref039
  article-title: Prognostic role of neutrophil to lymphocyte ratio in solid tumors: a systematic review and meta-analysis
  publication-title: J. Natl. Cancer Inst
  doi: 10.1093/jnci/dju124
  contributor:
    fullname: AJ Templeton
– volume: 341
  start-page: 15
  year: 2010
  ident: pone.0232230.ref045
  article-title: Chemokine decoy receptors: structure-function and biological properties
  publication-title: Curr. Top. Microbiol Immunol
  contributor:
    fullname: R Bonecchi
– volume: 56
  start-page: 3596
  year: 2011
  ident: pone.0232230.ref017
  article-title: Serum interleukin-33 levels in patients with gastric cancer
  publication-title: Dig. Dis. Sci
  doi: 10.1007/s10620-011-1760-5
  contributor:
    fullname: P Sun
– volume: 70
  start-page: 358
  year: 2016
  ident: pone.0232230.ref041
  article-title: Change in Neutrophil-to-lymphocyte ratio in response to targeted therapy for metastatic renal cell carcinoma as a prognosticator and biomarker of efficacy
  publication-title: Eur. Urol
  doi: 10.1016/j.eururo.2016.02.033
  contributor:
    fullname: AJ Templeton
– volume: 165
  start-page: 5269
  year: 2000
  ident: pone.0232230.ref036
  article-title: The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR + CXC chemokine-induced angiogenic activity
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.165.9.5269
  contributor:
    fullname: CL Addison
– volume: 16
  start-page: 137
  year: 2017
  ident: pone.0232230.ref038
  article-title: Neutrophils in cancer: prognostic role and therapeutic strategies
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-017-0707-7
  contributor:
    fullname: A Ocana
– volume: 194
  start-page: 438
  year: 2015
  ident: pone.0232230.ref024
  article-title: Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.1401344
  contributor:
    fullname: X Gao
– volume: 13
  start-page: 1176
  year: 1994
  ident: pone.0232230.ref010
  article-title: Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor
  publication-title: EMBO J
  doi: 10.1002/j.1460-2075.1994.tb06367.x
  contributor:
    fullname: G Bergers
– volume: 32
  start-page: 1520
  year: 2002
  ident: pone.0232230.ref011
  article-title: Expression and function of the ST2 gene in a murine model of allergic airway inflammation
  publication-title: Clin. Exp. Allergy
  doi: 10.1046/j.1365-2745.2002.01494.x
  contributor:
    fullname: K Oshikawa
– year: 2018
  ident: pone.0232230.ref047
  article-title: Role of the IL-33/ST2L axis in colorectal cancer progression
  publication-title: Cell. Immunol
  contributor:
    fullname: M Akimoto
– volume: 9
  start-page: 9
  year: 2012
  ident: pone.0232230.ref005
  article-title: Radiotherapy: the importance of local control in pancreatic cancer
  publication-title: Nat. Rev. Clin. Oncol
  doi: 10.1038/nrclinonc.2011.182
  contributor:
    fullname: E Ben-Josef
– volume: 10
  start-page: 323
  year: 2013
  ident: pone.0232230.ref004
  article-title: Advanced-stage pancreatic cancer: therapy options
  publication-title: Nat. Rev. Clin. Oncol
  doi: 10.1038/nrclinonc.2013.66
  contributor:
    fullname: J Werner
– volume: 4
  start-page: 55
  year: 2017
  ident: pone.0232230.ref040
  article-title: An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration
  publication-title: Regen. Biomater
  doi: 10.1093/rb/rbw041
  contributor:
    fullname: GS Selders
– volume: 134
  start-page: 1669
  year: 2014
  ident: pone.0232230.ref020
  article-title: Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.28481
  contributor:
    fullname: IP Jovanovic
– volume: 42
  start-page: 729
  year: 2013
  ident: pone.0232230.ref002
  article-title: Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?
  publication-title: Pancreas
  doi: 10.1097/MPA.0b013e318288107a
  contributor:
    fullname: C. Partensky
– volume: 10
  start-page: e0126605
  year: 2015
  ident: pone.0232230.ref027
  article-title: Anticancer effect of ginger extract against pancreatic cancer cells mainly through reactive oxygen species-mediated autotic cell death
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0126605
  contributor:
    fullname: M Akimoto
– volume: 258
  start-page: 301
  year: 1989
  ident: pone.0232230.ref006
  article-title: A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(89)81679-5
  contributor:
    fullname: S. Tominaga
– volume: 40
  start-page: 1654
  year: 2012
  ident: pone.0232230.ref019
  article-title: Detection of interleukin-33 in serum and carcinoma tissue from patients with hepatocellular carcinoma and its clinical implications
  publication-title: J. Int. Med. Res
  doi: 10.1177/030006051204000504
  contributor:
    fullname: P Zhang
– volume: 20
  start-page: 14717
  year: 2014
  ident: pone.0232230.ref001
  article-title: Novel strategies for managing pancreatic cancer
  publication-title: World J. Gastroenterol
  doi: 10.3748/wjg.v20.i40.14717
  contributor:
    fullname: WS Loc
– volume: 14
  start-page: 2563
  year: 2013
  ident: pone.0232230.ref018
  article-title: Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer
  publication-title: Asian Pac. J. Cancer Prev
  doi: 10.7314/APJCP.2013.14.4.2563
  contributor:
    fullname: L-A Hu
– volume: 27
  start-page: 4709
  year: 2009
  ident: pone.0232230.ref042
  article-title: Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma
  publication-title: J. Clin. Oncol
  doi: 10.1200/JCO.2008.18.9498
  contributor:
    fullname: HK Jensen
– volume: 285
  start-page: 1377
  year: 2001
  ident: pone.0232230.ref007
  article-title: Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V
  publication-title: Biochem. Biophys. Res. Commun
  doi: 10.1006/bbrc.2001.5306
  contributor:
    fullname: K Tago
– volume: 335
  start-page: 463
  year: 2013
  ident: pone.0232230.ref023
  article-title: Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2013.03.002
  contributor:
    fullname: K Gao
– volume: 8
  start-page: 5885
  year: 2017
  ident: pone.0232230.ref049
  article-title: A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic cancer patient-derived xenografts
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.11809
  contributor:
    fullname: M Hoover
– volume: 34
  start-page: 23
  year: 2017
  ident: pone.0232230.ref026
  article-title: IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer
  publication-title: Med. Oncol
  doi: 10.1007/s12032-016-0880-3
  contributor:
    fullname: Y Fang
– volume: 3
  start-page: 122375
  issue: 20
  year: 2018
  ident: pone.0232230.ref044
  article-title: Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.122375
  contributor:
    fullname: P Andersson
– volume: 33
  start-page: 7
  year: 2010
  ident: pone.0232230.ref046
  article-title: The mysterious ways of the chemokine CXCL5
  publication-title: Immunity
  doi: 10.1016/j.immuni.2010.07.012
  contributor:
    fullname: EK Koltsova
– volume: 289
  start-page: H1976
  year: 2005
  ident: pone.0232230.ref031
  article-title: GRO family chemokines are specialized for monocyte arrest from flow
  publication-title: Am. J. Physiol. Heart Circ. Physiol
  doi: 10.1152/ajpheart.00153.2005
  contributor:
    fullname: DF Smith
– volume: 23
  start-page: 479
  year: 2005
  ident: pone.0232230.ref016
  article-title: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
  publication-title: Immunity
  doi: 10.1016/j.immuni.2005.09.015
  contributor:
    fullname: J Schmitz
– volume: 3
  start-page: e3331
  year: 2008
  ident: pone.0232230.ref012
  article-title: The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’?
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0003331
  contributor:
    fullname: C Moussion
– volume: 384
  start-page: 105
  year: 2009
  ident: pone.0232230.ref013
  article-title: IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes
  publication-title: Biochem. Biophys. Res. Commun
  doi: 10.1016/j.bbrc.2009.04.081
  contributor:
    fullname: IS Wood
– volume: 7
  start-page: 13589
  year: 2016
  ident: pone.0232230.ref022
  article-title: Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumor microenvironment
  publication-title: Nat. Commun
  doi: 10.1038/ncomms13589
  contributor:
    fullname: M Akimoto
– volume: 37
  start-page: 2757
  year: 2018
  ident: pone.0232230.ref048
  article-title: Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells
  publication-title: Oncogene
  doi: 10.1038/s41388-018-0144-0
  contributor:
    fullname: K Takahashi
– volume: 10
  start-page: 301
  year: 2016
  ident: pone.0232230.ref003
  article-title: The role of hypoxia in pancreatic cancer: a potential therapeutic target?
  publication-title: Expert Rev. Gastroenterol. Hepatol
  doi: 10.1586/17474124.2016.1117386
  contributor:
    fullname: M Erkan
– volume: 175
  start-page: 5351
  year: 2005
  ident: pone.0232230.ref037
  article-title: The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma
  publication-title: J. Immunol
  doi: 10.4049/jimmunol.175.8.5351
  contributor:
    fullname: J Mestas
– volume: 1
  start-page: 13
  year: 2009
  ident: pone.0232230.ref030
  article-title: Chemokines and B cells in renal inflammation and allograft rejection
  publication-title: Front. Biosci (Schol Ed)
  doi: 10.2741/s2
  contributor:
    fullname: OM Steinmetz
– volume: 271
  start-page: 20545
  year: 1996
  ident: pone.0232230.ref032
  article-title: The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.271.34.20545
  contributor:
    fullname: SK Ahuja
– volume: 71
  start-page: i101
  year: 2012
  ident: pone.0232230.ref008
  article-title: IL-33: a Janus cytokine
  publication-title: Ann. Rheum. Dis
  doi: 10.1136/annrheumdis-2011-200589
  contributor:
    fullname: FY Liew
– volume: 60
  start-page: 514
  year: 2012
  ident: pone.0232230.ref025
  article-title: Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2012.06.286
  contributor:
    fullname: A Schmieder
– volume: 15
  start-page: 87
  year: 2004
  ident: pone.0232230.ref009
  article-title: T1/ST2—an IL-1 receptor-like modulator of immune responses
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2004.02.004
  contributor:
    fullname: V Trajkovic
– volume: 816
  start-page: 25
  year: 2014
  ident: pone.0232230.ref021
  article-title: The role of inflammation in colon cancer
  publication-title: Adv. Exp. Med. Biol
  doi: 10.1007/978-3-0348-0837-8_2
  contributor:
    fullname: NB Janakira
– volume: 60
  start-page: 180
  year: 2014
  ident: pone.0232230.ref043
  article-title: Chemokines induced in human respiratory epithelial cells by IL-1 family of cytokines
  publication-title: Folia Biol (Praha)
  doi: 10.14712/fb2014060040180
  contributor:
    fullname: E Brabcová
– volume: 10
  start-page: 103
  year: 2010
  ident: pone.0232230.ref015
  article-title: Disease-associated functions of IL-33: the new kid in the IL-1 family
  publication-title: Nat. Rev. Immunol
  doi: 10.1038/nri2692
  contributor:
    fullname: FY Liew
– volume: 44
  start-page: 717
  year: 1984
  ident: pone.0232230.ref028
  article-title: Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice
  publication-title: Cancer Res
  contributor:
    fullname: TH Corbett
– volume: 15
  start-page: 756
  year: 2011
  ident: pone.0232230.ref033
  article-title: Microparticles stimulate angiogenesis by inducing ELR(+) CXC-chemokines in synovial fibroblasts
  publication-title: J. Cell Mol. Med
  doi: 10.1111/j.1582-4934.2010.01051.x
  contributor:
    fullname: N Reich
– volume: 270
  start-page: 27348
  year: 1995
  ident: pone.0232230.ref035
  article-title: The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.270.45.27348
  contributor:
    fullname: RM Strieter
– volume: 59
  start-page: 143
  year: 2010
  ident: pone.0232230.ref014
  article-title: IL-33 and IL-33 receptors in host defense and diseases
  publication-title: Allergol. Int.
  doi: 10.2332/allergolint.10-RAI-0186
  contributor:
    fullname: K Oboki
– volume: 107
  start-page: 18581
  year: 2010
  ident: pone.0232230.ref029
  article-title: IL-33 is a crucial amplifier of innate rather than acquired immunity
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1003059107
  contributor:
    fullname: K Oboki
– volume: 267
  start-page: 226
  year: 2008
  ident: pone.0232230.ref034
  article-title: The role of CXC chemokines and their receptors in cancer
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2008.04.050
  contributor:
    fullname: J Vandercappellen
SSID ssj0053866
Score 2.4167407
Snippet Proinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells. However, the role...
Background Proinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells....
BACKGROUNDProinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells....
BackgroundProinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells....
Background Proinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in inflammation and the malignant behavior of cancer cells....
SourceID plos
doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0232230
SubjectTerms Biology and Life Sciences
Cancer cells
CD20 antigen
Chemokines
Colon
Colon cancer
Colorectal cancer
CXCR2 protein
Cytokines
Enzyme-linked immunosorbent assay
Fibroblasts
Gene expression
Growth
House mouse
Immunohistochemistry
Inflammation
Interleukins
Laboratory animals
Leukocytes (neutrophilic)
Macrophages
Medicine and Health Sciences
Messenger RNA
Pancreas
Pancreatic cancer
Pharmaceutical industry
R&D
Receptors
Research & development
Research and Analysis Methods
RNA
Signaling
Therapeutic applications
Time
Tissues
Tumor cell lines
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquBAgYhAQe3ceLEybFUVAUJkGiLerMc2-muaJNok1Sq-PPMxNmoQZXgwHU9cTYz45n5_PhMyJskt7krdcI4tzkTkeYsS0vHhLFa5FkR22G54MvX9OhUfD5Lzm5c9YV7wjw9sFfcnoGnIKtwnhoorguRJaHhVhvjkgJyVTlEX55swJSPwTCK03Q8KBdLvjfaZbepK7cLWQpyYjhLRANf_xSVF81F3d5Wcv65c_JGKjq8T-6NNSTd9_99i9xx1QOyNY7Slr4bqaTfPyS_DtCoa4rT88yCs105S5EhYn3h-p-risUxtQBArykEPtcA_qbt8UlEXbXUQ1-4qlN3dbMytOsvofkcYHu3hD6oppc4U-8oxBNfehpq_OuG63UekdPDjycHR2y8boEZAA0dk4CEcshnXDrAgVDHWAnoAxcGeWlMxFNccw2dscjiV0BaL6D4KQTo0unCASh_TBYVKHibUAEoJpWl4LwEAZcVGlAjAEkbS8uLOAsI2-heNZ5VQw1LaxLQiFeiQlup0VYB-YAGmmSRE3v4ATxFjZ6i_uYpAXmJ5lX-gOk0stV-GoEHSYCKAXk9SCAvRoUbb85137bq07cf_yB0_H0m9HYUKmtwFKPHww7wTci3NZPcmUnC6Daz5m10xo1WWhXFeYIsj5GEJzcOenvzq6kZO8XNdJWrey-TQmzH3p94f540G0exwDo4IHLm6TPVz1uq1XKgJZdIKxaKp__DVs_I3QgnNkLBIrlDFt26d8-h-uuKF8NA_w1bu1dh
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZG98ILYtxWGGAQEvDgtU6cuHlC27SpIDHQLmhvkW9pK7Yka9JJiD_POYlTCJoQr_WJ05z752MfE_ImSmziMhUxzm3CRKA4m8SZY8JYJZKJDm1TLvh8HE_PxaeL6GKDTLuzMLitsvOJjaO2hcE18lEQJhF2twOorjSuAph69KG8Znh_FNZZ_WUad8hmwAUWbDf3D4-_nnReGew6jv3RuVDykZfUblnkbhfiFkTJcS80NR381356UF4W1W1J6N97Kf8ITkf3yT2fVdK9Vg22yIbLH5Atb7cVfeebS79_SH4eoJiXFBfsmQX1u3GWYs-I5aVbfV_kLAypBUj6g4IrdCUgclqdngXU5XPVzIV1nqIuyoWh9eoKhmcA5Os5zEEVvcK1e0fBw7TJqKGmfV1z4c4jcn50eHYwZf4CBmYARtRMAjZKIMJx6QAZQmZjJeARLBXyzJiAx1iFHTtjsa-fhkCvIR3SAnjplHYA0x-TQQ4M3iZUAK6JZSY4z4DATbQCHAnQ0obSch1OhoR1vE_Lts9G2hTbJOCTlokpyir1shqSfRTQmha7ZDc_FMtZ6o0uNaBxkJFwHhsAZlpMorHhVhnjIg15TjYkL1G8aXvkdG3r6V4cAC6WAB6H5HVDgZ0yctyKM1Orqko_fvn2H0SnJz2it54oK1B7lT_-AN-EHbh6lDs9SrB30xveRmXsuFKlvy0DnuwU9PbhV-thnBS31-WuWLU0MXh7nP1Jq89rzoZBKDAzHhLZ0_Qe6_sj-WLeNCqX2GhsLJ7--289I3cDXMQYCxbIHTKolyv3HDK9Wr_wRvwLYUVTpQ
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELam7oUXxMaPdQwwCAl4cFU7Tpw8IDQmpoE0kNiK9hYlttNWdEloEsTEP8-dk0YEFWmv8cVRzne--3z2Z0Je-pGJbJb4jHMTMSkSzsIgs0xqk8goTD3jygXnn4Ozmfx05V_tkM2drZ0Cq63QDu-Tmq1Xk18_bt6Bw791tzYovnlpUha5nUAMgogHIH5XSE-izZ_Lvq4A3u2ql5i1sEBMve4w3f96GQQrx-nfz9yjclVU29LSf3dX_hWuTu-Ru12eSY9bw9gjOzbfJ3udJ1f0dUc3_eY--X2CA7-muITPDBjkT2soskisV7b5vsyZ51EDIPWGwuRoS8DotLq4FNTmi8T1hZWfoi7KpaZ1cw3Nc4D29QL6oAm9xtV8S2HOadNTTXX7OXcFzwMyO_1weXLGuisZmAZgUTMFaCmCmMeVBawIuY5RgFCweMgzrQUPsC47tdog018KoT-FBCmVoEubpBaA-0MyykHBB4RKQDqByiTnGQjYME0AWQLYNJ4yPPXCMWEb3cdly7wRu_KbAsTSKjHGsYq7sRqT9zhAvSzyZrsHxXoed24Ya7BByFE4DzRAtVSG_lRzk2ht_RQyn2xMnuHwxu0h1N774-NAAFJWACfH5IWTQO6MHDfnzJOmquKPX77dQuji60DoVSeUFWAoOukORMA_ISfXQPJoIAkzgB40H6AxbrRSxcKLfGSCFAre3Bjo9ubnfTN2ihvucls0rUwA8z_2_qi1516znvAk5spjogaWPlD9sCVfLhx1uULqsak8vPWvPyZ3BK5wTCUT6oiM6nVjn0AaWKdPnWf_AW9JWj4
  priority: 102
  providerName: Scholars Portal
Title Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model
URI https://www.ncbi.nlm.nih.gov/pubmed/32340025
https://www.proquest.com/docview/2395249227/abstract/
https://search.proquest.com/docview/2395630749
https://pubmed.ncbi.nlm.nih.gov/PMC7185704
https://doaj.org/article/c4cd381116c548b4850c1dacce5b129f
http://dx.doi.org/10.1371/journal.pone.0232230
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLe2cuGCGF8LjGIQEnBIWydOnBy3qmUgdUz7QL1Fie20FW0SNSkSQuJv5z0nqQjaAXHxoX5x2_f9s59fCHnrhSrUaezZjKnQ5k7M7MBPtc2linkYJK4yxwWzC__8ln-ee_MD4rV3YUzRvkxWg2y9GWSrpamtLDZy2NaJDS9nY4ENjEZ8eEgOheu2EL12v2DAvt_ckXMFGzYiGRR5pgcQoCAc4tvfXMflGO874ch07d_75l6xzsu7Es-_6yf_CEjTh-RBk0nS0_oXH5EDnT0iR42tlvR901D6w2Pyc4yi3VLcpLcVqNx3rSj2idiu9e7bKrNdlyqAoT8ouD9dAAqn5fWNQ3W2jM1aeLaTV3mxkrTabWB6AeC9WsIaNKYb3K_XFLxKnYBKKuuvMy_ZeUJup5Ob8bndvHTBlgAdKlsAHgohqjGhAQ1CNqMEYBA8HmSplA7z8eR1pKXCXn4JBPcEUqCEA1t1nGiA5k9JLwNeHxPKAcv4IuWMpUCggyQG7AhwUrlCscQNLGK3vI-KurdGZA7YBGCSmokRii1qxGaRMxTQnhY7Y5sP8u0iavQjkqBlkIUw5ksAYwkPvJFkKpZSewnkNqlFXqF4o_qa6d6-o1PfASwsADBa5I2hwO4YGZbfLOJdWUafvnz9B6Lrqw7Ru4YozUFRZNxceYD_hF23OpQnHUqwcdmZPkZlbLlSRo4betjr0RHwZKugd0-_3k_jolhSl-l8V9P44OFx9We1Pu8521qHRURH0zus786ArZrm5I1tPv_vJ1-Q-w7uaYy47YgT0qu2O_0SEr8q6YO5zwWMwZjhOP3YJ_fOJheXV32zlQLjjAc4_pr0jVP4DWr7Xp8
link.rule.ids 230,315,733,786,790,870,891,2115,2236,12083,12250,12792,21416,24346,27957,27958,31754,31755,33301,33302,33408,33409,33779,33780,43345,43614,43635,43840,53827,53829,74102,74371,74392,74659
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3Nb9MwFLegHOAyMb5WGMwgJODgrY6duDmhMTF1sA2JdWg3K7GdtmJLQpMiIf553kvcQNCEuNYvTvO-f372MyEvw9jGLktCxrmNmQwSzsZR5pg0NpHxOBW2KRecnEaTc_nhIrzwC26V31a59omNo7aFwTXyvUDEIXa3C9Tb8hvDW6Owuuqv0LhJbkkhJG7pUxcd4AJbjiJ_XE4ovuels1sWuduFWAWRcdQLR03X_s43D8rLorou8fx7_-QfAenwLtnwmSTdb0W_SW64_B7Z9LZa0de-ofSb--TnAYp2SXGRnllQue_OUuwTsbx0q6-LnAlBLcDQHxTcnysBhdPqbBpQl8-TZi6s7RR1US4MrVdXMDwD8F7PYQ6a0Ctcr3cUvEqbgBpq2tc1l-w8IOeH76cHE-YvXWAGoEPNFOChGKIaVw7QIGQzVgEGwfIgz4wJeISV15EzFnv5pRDcU0iBUgm8dEnqAJo_JIMcGLxFqAQsE6lMcp4BgRunCWBHgJNWKMtTMR4Stua9LtveGropsCnAJC0TNcpKe1kNyTsUUEeLnbGbH4rlTHtD0wa0DLIQziMDYCyV43BkuE2McWEKuU02JDsoXt0eM-3sW-9HAWBhBYBxSF40FNgdI8ftN7NkVVX66NOX_yA6-9wjeuWJsgIUxST-yAN8E3bd6lFu9yjBxk1veAuVcc2VSv-2BnhyraDXDz_vhnFS3FKXu2LV0kTg4XH2R60-d5wVgZCYDQ-J6ml6j_X9kXwxb5qTK2wuNpKP__23dsjtyfTkWB8fnX58Qu4EuIgxkixQ22RQL1fuKWR6dfqsMedf9lVRcg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLagSIgXxLgtMJhBSMCDtzhx4uYJjUG1cRmIXdQ3K7GdtmJLQpMiIf485yRuIGhCvNYnTnPun499TMizKDGJzdOIcW4SJoKUs3GcWya0SUUyzkLTlgs-HsUHp-LdNJq6_U-121a59omtozalxjXy3SBMIuxuB1A9d9siPr-ZvKq-MbxBCiut7jqNq-QaREkfbzOQ0x58gV3HsTs6F0q-6yS1U5WF3YG4BVHSH4SmtoN_76dH1XlZX5aE_r2X8o_gNLlFbrqsku51arBBrtjiNtlwdlvTF6659Ms75Oc-inlJccGeGVC_79ZQ7BmxPLerr4uChSE1AEl_UHCFtgJETuvjk4DaYp62c2Gdp2zKaqFps7qA4RkA-WYOc9CUXuDavaXgYbpkVFPdva69cOcuOZ28Pdk_YO4CBqYBRjRMAjZKIMJxaQEZQmZjJOARLBXyXOuAx1iF9a022Ncvg0CfQTqUCeClTTMLMP0eGRXA4E1CBeCaWOaC8xwI7DhLAUcCtDShNDwLxx5ha96rquuzodpimwR80jFRoayUk5VHXqOAelrskt3-UC5nyhmd0qBxkJFwHmsAZpkYR77mJtXaRhnkOblHtlG8qjty2tu62osDwMUSwKNHnrYU2CmjQJ2bpau6Voefzv6D6PjLgOi5I8pLUBSduuMP8E3YgWtAuTWgBHvXg-FNVMY1V2r12zLgybWCXj78pB_GSXF7XWHLVUcTg7fH2e93-txzNgxCgZmxR-RA0wesH44Ui3nbqFxiozFfPPj339om18GS1YfDo_cPyY0A1zN8wQK5RUbNcmUfQdLXZI9ba_4F3_lVng
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cancer+cell-derived+interleukin-33+decoy+receptor+sST2+enhances+orthotopic+tumor+growth+in+a+murine+pancreatic+cancer+model&rft.jtitle=PloS+one&rft.au=Takenaga%2C+Keizo&rft.au=Akimoto%2C+Miho&rft.au=Koshikawa%2C+Nobuko&rft.au=Nagase%2C+Hiroki&rft.date=2020-04-27&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=15&rft.issue=4&rft.spage=e0232230&rft_id=info:doi/10.1371%2Fjournal.pone.0232230&rft.externalDocID=A622117149
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon